Balyasny Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-315,686
| Closed | -$2.62M | – | 2213 |
|
|
2024
Q3 | $2.62M | Buy |
315,686
+262,248
| +491% | +$2.18M | ﹤0.01% | 1055 |
|
|
2024
Q2 | $383K | Sell |
53,438
-432,767
| -89% | -$3.1M | ﹤0.01% | 1540 |
|
|
2024
Q1 | $4.22M | Sell |
486,205
-9,221
| -2% | -$79.9K | 0.01% | 910 |
|
|
2023
Q4 | $3.25M | Sell |
495,426
-82,061
| -14% | -$537K | 0.01% | 908 |
|
|
2023
Q3 | $5.77M | Sell |
577,487
-101,716
| -15% | -$1.02M | 0.01% | 748 |
|
|
2023
Q2 | $8.44M | Buy |
+679,203
| New | +$8.44M | 0.02% | 649 |
|
|
2023
Q1 | – | Sell |
-1,776,511
| Closed | -$25.4M | – | 2480 |
|
|
2022
Q4 | $25.4M | Buy |
1,776,511
+724,950
| +69% | +$10.4M | 0.07% | 308 |
|
|
2022
Q3 | $26.8M | Buy |
1,051,561
+496,874
| +90% | +$12.7M | 0.08% | 267 |
|
|
2022
Q2 | $15.8M | Buy |
554,687
+223,792
| +68% | +$6.36M | 0.05% | 409 |
|
|
2022
Q1 | $11.7M | Buy |
+330,895
| New | +$11.7M | 0.04% | 501 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2205 |
|
|
2021
Q2 | – | Sell |
-465,542
| Closed | -$16.6M | – | 1916 |
|
|
2021
Q1 | $16.6M | Sell |
465,542
-533,129
| -53% | -$19M | 0.08% | 283 |
|
|
2020
Q4 | $28M | Buy |
+998,671
| New | +$28M | 0.16% | 163 |
|